Bide Pharmatech Co., Ltd. (SHA:688073)
China
· Delayed Price · Currency is CNY 43.83
+0.04 (0.09%)
Last updated: Jun 3, 2025
Bide Pharmatech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Net Income | 122.04 | 117.43 | 109.57 | 145.97 | 97.57 | 59 | Upgrade
|
| Depreciation & Amortization | 28.43 | 28.43 | 26.93 | 17.61 | 10.67 | 2.48 | Upgrade
|
| Other Amortization | 15.25 | 15.25 | 14.16 | 8.62 | 7.47 | 5.61 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.86 | -0.86 | -0.44 | - | -7.92 | -0.09 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.03 | 0.03 | 0 | 0 | 0.04 | 0.55 | Upgrade
|
| Loss (Gain) From Sale of Investments | -5.98 | -5.98 | 8.87 | 0.4 | -0.41 | -0.5 | Upgrade
|
| Provision & Write-off of Bad Debts | 1.75 | 1.75 | 4.33 | 3.52 | 3.06 | 2.24 | Upgrade
|
| Other Operating Activities | -4.46 | 41.23 | 20.11 | -5.92 | 11.97 | 14.69 | Upgrade
|
| Change in Accounts Receivable | 10.05 | 10.05 | -45.02 | -74.5 | -58.02 | -16.88 | Upgrade
|
| Change in Inventory | -96.65 | -96.65 | -196.27 | -52.81 | -267.2 | -97.03 | Upgrade
|
| Change in Accounts Payable | 43.2 | 43.2 | -1.58 | -14.89 | 134.92 | 25.74 | Upgrade
|
| Change in Other Net Operating Assets | 1.69 | 1.69 | 12.32 | - | 1.99 | 8.97 | Upgrade
|
| Operating Cash Flow | 117.24 | 158.31 | -57.39 | 29.87 | -64.88 | 3.65 | Upgrade
|
| Operating Cash Flow Growth | 858.05% | - | - | - | - | 21.97% | Upgrade
|
| Capital Expenditures | -86.96 | -88.35 | -61.08 | -38.41 | -29.2 | -37.73 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.2 | 2.2 | 0.93 | - | 15.15 | 0.31 | Upgrade
|
| Investment in Securities | -820.29 | -77.92 | - | 0.59 | 43.41 | -42.5 | Upgrade
|
| Other Investing Activities | 5.81 | 5.59 | 4.06 | -4.79 | - | - | Upgrade
|
| Investing Cash Flow | -899.25 | -158.48 | -28.87 | -42.61 | 29.36 | -79.92 | Upgrade
|
| Short-Term Debt Issued | - | 97.35 | 0.23 | - | 20.73 | 33.57 | Upgrade
|
| Long-Term Debt Issued | - | 5.6 | 4.98 | 9.61 | - | - | Upgrade
|
| Total Debt Issued | 294.7 | 102.94 | 5.21 | 9.61 | 20.73 | 33.57 | Upgrade
|
| Short-Term Debt Repaid | - | -68.01 | -9.53 | - | -37.69 | -41.65 | Upgrade
|
| Long-Term Debt Repaid | - | -21.88 | -21.83 | -13.89 | -8.53 | - | Upgrade
|
| Total Debt Repaid | -98.76 | -89.89 | -31.36 | -13.89 | -46.22 | -41.65 | Upgrade
|
| Net Debt Issued (Repaid) | 195.93 | 13.06 | -26.14 | -4.28 | -25.49 | -8.09 | Upgrade
|
| Issuance of Common Stock | - | - | - | 1,335 | 163.9 | 160.25 | Upgrade
|
| Repurchase of Common Stock | -100.02 | -100.02 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -81.56 | -79.88 | -100.03 | -0.08 | -0.19 | -24.91 | Upgrade
|
| Other Financing Activities | 40.65 | - | -12.13 | -20.52 | -0.77 | - | Upgrade
|
| Financing Cash Flow | 55.01 | -166.84 | -138.31 | 1,310 | 137.44 | 127.25 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.94 | -1.44 | -5.83 | 4.73 | -0.3 | -3.56 | Upgrade
|
| Net Cash Flow | -725.06 | -168.45 | -230.39 | 1,302 | 101.62 | 47.42 | Upgrade
|
| Free Cash Flow | 30.28 | 69.97 | -118.47 | -8.54 | -94.09 | -34.08 | Upgrade
|
| Free Cash Flow Margin | 2.67% | 6.35% | -10.85% | -1.02% | -15.52% | -8.71% | Upgrade
|
| Free Cash Flow Per Share | 0.34 | 0.79 | -1.31 | -0.12 | -1.41 | -0.55 | Upgrade
|
| Cash Income Tax Paid | 9.08 | 19.77 | 2.5 | 25.48 | 12.74 | 14.34 | Upgrade
|
| Levered Free Cash Flow | -14.47 | 26.94 | -188.91 | -43.78 | -120.54 | -82.71 | Upgrade
|
| Unlevered Free Cash Flow | -11.53 | 29.01 | -187.33 | -42.42 | -119.96 | -81.54 | Upgrade
|
| Change in Net Working Capital | 50.95 | -1.75 | 232.9 | 120.45 | 178.13 | 108.44 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.